0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Cell and Gene Therapy CRO Market Research Report 2024
Published Date: April 2024
|
Report Code: QYRE-Auto-23Q16547
Home | Market Reports | Health| Nursing
Global Cell and Gene Therapy CRO Market Research Report 2024
BUY CHAPTERS

Global Cell and Gene Therapy CRO Market Research Report 2024

Code: QYRE-Auto-23Q16547
Report
April 2024
Pages:86
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Cell and Gene Therapy CRO Market

A Cell and Gene Therapy Contract Research Organization (CRO) is a specialized service provider that offers support and expertise in conducting preclinical and clinical research for cell and gene therapy products. These CROs play a crucial role in advancing the development of cell and gene therapies by providing a wide range of services tailored to the unique requirements of these innovative treatments.
The global Cell and Gene Therapy CRO market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Cell and Gene Therapy CRO is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Cell and Gene Therapy CRO is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Cell and Gene Therapy CRO in SMBs is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Cell and Gene Therapy CRO include Labcorp, IQVIA Biotech, PPD, Medpace, Veristat, Parexel, Charles River Laboratories, Catalent Pharma Solutions, Premier Research, Catalent, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Cell and Gene Therapy CRO, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cell and Gene Therapy CRO.
The Cell and Gene Therapy CRO market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Cell and Gene Therapy CRO market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cell and Gene Therapy CRO companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Cell and Gene Therapy CRO Market Report

Report Metric Details
Report Name Cell and Gene Therapy CRO Market
Segment by Type
  • Preclinical CRO
  • Clinical CRO
Segment by Application
  • SMBs
  • Large Companies
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Labcorp, IQVIA Biotech, PPD, Medpace, Veristat, Parexel, Charles River Laboratories, Catalent Pharma Solutions, Premier Research, Catalent, Vial, Noble Life Sciences, Ergomed
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Cell and Gene Therapy CRO company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Cell and Gene Therapy CRO Market report?

Ans: The main players in the Cell and Gene Therapy CRO Market are Labcorp, IQVIA Biotech, PPD, Medpace, Veristat, Parexel, Charles River Laboratories, Catalent Pharma Solutions, Premier Research, Catalent, Vial, Noble Life Sciences, Ergomed

What are the Application segmentation covered in the Cell and Gene Therapy CRO Market report?

Ans: The Applications covered in the Cell and Gene Therapy CRO Market report are SMBs, Large Companies

What are the Type segmentation covered in the Cell and Gene Therapy CRO Market report?

Ans: The Types covered in the Cell and Gene Therapy CRO Market report are Preclinical CRO, Clinical CRO

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cell and Gene Therapy CRO Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Preclinical CRO
1.2.3 Clinical CRO
1.3 Market by Application
1.3.1 Global Cell and Gene Therapy CRO Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 SMBs
1.3.3 Large Companies
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cell and Gene Therapy CRO Market Perspective (2019-2030)
2.2 Global Cell and Gene Therapy CRO Growth Trends by Region
2.2.1 Global Cell and Gene Therapy CRO Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Cell and Gene Therapy CRO Historic Market Size by Region (2019-2024)
2.2.3 Cell and Gene Therapy CRO Forecasted Market Size by Region (2025-2030)
2.3 Cell and Gene Therapy CRO Market Dynamics
2.3.1 Cell and Gene Therapy CRO Industry Trends
2.3.2 Cell and Gene Therapy CRO Market Drivers
2.3.3 Cell and Gene Therapy CRO Market Challenges
2.3.4 Cell and Gene Therapy CRO Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cell and Gene Therapy CRO Players by Revenue
3.1.1 Global Top Cell and Gene Therapy CRO Players by Revenue (2019-2024)
3.1.2 Global Cell and Gene Therapy CRO Revenue Market Share by Players (2019-2024)
3.2 Global Cell and Gene Therapy CRO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Cell and Gene Therapy CRO Revenue
3.4 Global Cell and Gene Therapy CRO Market Concentration Ratio
3.4.1 Global Cell and Gene Therapy CRO Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cell and Gene Therapy CRO Revenue in 2023
3.5 Global Key Players of Cell and Gene Therapy CRO Head office and Area Served
3.6 Global Key Players of Cell and Gene Therapy CRO, Product and Application
3.7 Global Key Players of Cell and Gene Therapy CRO, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Cell and Gene Therapy CRO Breakdown Data by Type
4.1 Global Cell and Gene Therapy CRO Historic Market Size by Type (2019-2024)
4.2 Global Cell and Gene Therapy CRO Forecasted Market Size by Type (2025-2030)
5 Cell and Gene Therapy CRO Breakdown Data by Application
5.1 Global Cell and Gene Therapy CRO Historic Market Size by Application (2019-2024)
5.2 Global Cell and Gene Therapy CRO Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Cell and Gene Therapy CRO Market Size (2019-2030)
6.2 North America Cell and Gene Therapy CRO Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Cell and Gene Therapy CRO Market Size by Country (2019-2024)
6.4 North America Cell and Gene Therapy CRO Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cell and Gene Therapy CRO Market Size (2019-2030)
7.2 Europe Cell and Gene Therapy CRO Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Cell and Gene Therapy CRO Market Size by Country (2019-2024)
7.4 Europe Cell and Gene Therapy CRO Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cell and Gene Therapy CRO Market Size (2019-2030)
8.2 Asia-Pacific Cell and Gene Therapy CRO Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Cell and Gene Therapy CRO Market Size by Region (2019-2024)
8.4 Asia-Pacific Cell and Gene Therapy CRO Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cell and Gene Therapy CRO Market Size (2019-2030)
9.2 Latin America Cell and Gene Therapy CRO Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Cell and Gene Therapy CRO Market Size by Country (2019-2024)
9.4 Latin America Cell and Gene Therapy CRO Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cell and Gene Therapy CRO Market Size (2019-2030)
10.2 Middle East & Africa Cell and Gene Therapy CRO Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Cell and Gene Therapy CRO Market Size by Country (2019-2024)
10.4 Middle East & Africa Cell and Gene Therapy CRO Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Labcorp
11.1.1 Labcorp Company Details
11.1.2 Labcorp Business Overview
11.1.3 Labcorp Cell and Gene Therapy CRO Introduction
11.1.4 Labcorp Revenue in Cell and Gene Therapy CRO Business (2019-2024)
11.1.5 Labcorp Recent Development
11.2 IQVIA Biotech
11.2.1 IQVIA Biotech Company Details
11.2.2 IQVIA Biotech Business Overview
11.2.3 IQVIA Biotech Cell and Gene Therapy CRO Introduction
11.2.4 IQVIA Biotech Revenue in Cell and Gene Therapy CRO Business (2019-2024)
11.2.5 IQVIA Biotech Recent Development
11.3 PPD
11.3.1 PPD Company Details
11.3.2 PPD Business Overview
11.3.3 PPD Cell and Gene Therapy CRO Introduction
11.3.4 PPD Revenue in Cell and Gene Therapy CRO Business (2019-2024)
11.3.5 PPD Recent Development
11.4 Medpace
11.4.1 Medpace Company Details
11.4.2 Medpace Business Overview
11.4.3 Medpace Cell and Gene Therapy CRO Introduction
11.4.4 Medpace Revenue in Cell and Gene Therapy CRO Business (2019-2024)
11.4.5 Medpace Recent Development
11.5 Veristat
11.5.1 Veristat Company Details
11.5.2 Veristat Business Overview
11.5.3 Veristat Cell and Gene Therapy CRO Introduction
11.5.4 Veristat Revenue in Cell and Gene Therapy CRO Business (2019-2024)
11.5.5 Veristat Recent Development
11.6 Parexel
11.6.1 Parexel Company Details
11.6.2 Parexel Business Overview
11.6.3 Parexel Cell and Gene Therapy CRO Introduction
11.6.4 Parexel Revenue in Cell and Gene Therapy CRO Business (2019-2024)
11.6.5 Parexel Recent Development
11.7 Charles River Laboratories
11.7.1 Charles River Laboratories Company Details
11.7.2 Charles River Laboratories Business Overview
11.7.3 Charles River Laboratories Cell and Gene Therapy CRO Introduction
11.7.4 Charles River Laboratories Revenue in Cell and Gene Therapy CRO Business (2019-2024)
11.7.5 Charles River Laboratories Recent Development
11.8 Catalent Pharma Solutions
11.8.1 Catalent Pharma Solutions Company Details
11.8.2 Catalent Pharma Solutions Business Overview
11.8.3 Catalent Pharma Solutions Cell and Gene Therapy CRO Introduction
11.8.4 Catalent Pharma Solutions Revenue in Cell and Gene Therapy CRO Business (2019-2024)
11.8.5 Catalent Pharma Solutions Recent Development
11.9 Premier Research
11.9.1 Premier Research Company Details
11.9.2 Premier Research Business Overview
11.9.3 Premier Research Cell and Gene Therapy CRO Introduction
11.9.4 Premier Research Revenue in Cell and Gene Therapy CRO Business (2019-2024)
11.9.5 Premier Research Recent Development
11.10 Catalent
11.10.1 Catalent Company Details
11.10.2 Catalent Business Overview
11.10.3 Catalent Cell and Gene Therapy CRO Introduction
11.10.4 Catalent Revenue in Cell and Gene Therapy CRO Business (2019-2024)
11.10.5 Catalent Recent Development
11.11 Vial
11.11.1 Vial Company Details
11.11.2 Vial Business Overview
11.11.3 Vial Cell and Gene Therapy CRO Introduction
11.11.4 Vial Revenue in Cell and Gene Therapy CRO Business (2019-2024)
11.11.5 Vial Recent Development
11.12 Noble Life Sciences
11.12.1 Noble Life Sciences Company Details
11.12.2 Noble Life Sciences Business Overview
11.12.3 Noble Life Sciences Cell and Gene Therapy CRO Introduction
11.12.4 Noble Life Sciences Revenue in Cell and Gene Therapy CRO Business (2019-2024)
11.12.5 Noble Life Sciences Recent Development
11.13 Ergomed
11.13.1 Ergomed Company Details
11.13.2 Ergomed Business Overview
11.13.3 Ergomed Cell and Gene Therapy CRO Introduction
11.13.4 Ergomed Revenue in Cell and Gene Therapy CRO Business (2019-2024)
11.13.5 Ergomed Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Cell and Gene Therapy CRO Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
 Table 2. Key Players of Preclinical CRO
 Table 3. Key Players of Clinical CRO
 Table 4. Global Cell and Gene Therapy CRO Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
 Table 5. Global Cell and Gene Therapy CRO Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 6. Global Cell and Gene Therapy CRO Market Size by Region (2019-2024) & (US$ Million)
 Table 7. Global Cell and Gene Therapy CRO Market Share by Region (2019-2024)
 Table 8. Global Cell and Gene Therapy CRO Forecasted Market Size by Region (2025-2030) & (US$ Million)
 Table 9. Global Cell and Gene Therapy CRO Market Share by Region (2025-2030)
 Table 10. Cell and Gene Therapy CRO Market Trends
 Table 11. Cell and Gene Therapy CRO Market Drivers
 Table 12. Cell and Gene Therapy CRO Market Challenges
 Table 13. Cell and Gene Therapy CRO Market Restraints
 Table 14. Global Cell and Gene Therapy CRO Revenue by Players (2019-2024) & (US$ Million)
 Table 15. Global Cell and Gene Therapy CRO Market Share by Players (2019-2024)
 Table 16. Global Top Cell and Gene Therapy CRO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell and Gene Therapy CRO as of 2023)
 Table 17. Ranking of Global Top Cell and Gene Therapy CRO Companies by Revenue (US$ Million) in 2023
 Table 18. Global 5 Largest Players Market Share by Cell and Gene Therapy CRO Revenue (CR5 and HHI) & (2019-2024)
 Table 19. Global Key Players of Cell and Gene Therapy CRO, Headquarters and Area Served
 Table 20. Global Key Players of Cell and Gene Therapy CRO, Product and Application
 Table 21. Global Key Players of Cell and Gene Therapy CRO, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Cell and Gene Therapy CRO Market Size by Type (2019-2024) & (US$ Million)
 Table 24. Global Cell and Gene Therapy CRO Revenue Market Share by Type (2019-2024)
 Table 25. Global Cell and Gene Therapy CRO Forecasted Market Size by Type (2025-2030) & (US$ Million)
 Table 26. Global Cell and Gene Therapy CRO Revenue Market Share by Type (2025-2030)
 Table 27. Global Cell and Gene Therapy CRO Market Size by Application (2019-2024) & (US$ Million)
 Table 28. Global Cell and Gene Therapy CRO Revenue Market Share by Application (2019-2024)
 Table 29. Global Cell and Gene Therapy CRO Forecasted Market Size by Application (2025-2030) & (US$ Million)
 Table 30. Global Cell and Gene Therapy CRO Revenue Market Share by Application (2025-2030)
 Table 31. North America Cell and Gene Therapy CRO Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 32. North America Cell and Gene Therapy CRO Market Size by Country (2019-2024) & (US$ Million)
 Table 33. North America Cell and Gene Therapy CRO Market Size by Country (2025-2030) & (US$ Million)
 Table 34. Europe Cell and Gene Therapy CRO Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 35. Europe Cell and Gene Therapy CRO Market Size by Country (2019-2024) & (US$ Million)
 Table 36. Europe Cell and Gene Therapy CRO Market Size by Country (2025-2030) & (US$ Million)
 Table 37. Asia-Pacific Cell and Gene Therapy CRO Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 38. Asia-Pacific Cell and Gene Therapy CRO Market Size by Region (2019-2024) & (US$ Million)
 Table 39. Asia-Pacific Cell and Gene Therapy CRO Market Size by Region (2025-2030) & (US$ Million)
 Table 40. Latin America Cell and Gene Therapy CRO Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 41. Latin America Cell and Gene Therapy CRO Market Size by Country (2019-2024) & (US$ Million)
 Table 42. Latin America Cell and Gene Therapy CRO Market Size by Country (2025-2030) & (US$ Million)
 Table 43. Middle East & Africa Cell and Gene Therapy CRO Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 44. Middle East & Africa Cell and Gene Therapy CRO Market Size by Country (2019-2024) & (US$ Million)
 Table 45. Middle East & Africa Cell and Gene Therapy CRO Market Size by Country (2025-2030) & (US$ Million)
 Table 46. Labcorp Company Details
 Table 47. Labcorp Business Overview
 Table 48. Labcorp Cell and Gene Therapy CRO Product
 Table 49. Labcorp Revenue in Cell and Gene Therapy CRO Business (2019-2024) & (US$ Million)
 Table 50. Labcorp Recent Development
 Table 51. IQVIA Biotech Company Details
 Table 52. IQVIA Biotech Business Overview
 Table 53. IQVIA Biotech Cell and Gene Therapy CRO Product
 Table 54. IQVIA Biotech Revenue in Cell and Gene Therapy CRO Business (2019-2024) & (US$ Million)
 Table 55. IQVIA Biotech Recent Development
 Table 56. PPD Company Details
 Table 57. PPD Business Overview
 Table 58. PPD Cell and Gene Therapy CRO Product
 Table 59. PPD Revenue in Cell and Gene Therapy CRO Business (2019-2024) & (US$ Million)
 Table 60. PPD Recent Development
 Table 61. Medpace Company Details
 Table 62. Medpace Business Overview
 Table 63. Medpace Cell and Gene Therapy CRO Product
 Table 64. Medpace Revenue in Cell and Gene Therapy CRO Business (2019-2024) & (US$ Million)
 Table 65. Medpace Recent Development
 Table 66. Veristat Company Details
 Table 67. Veristat Business Overview
 Table 68. Veristat Cell and Gene Therapy CRO Product
 Table 69. Veristat Revenue in Cell and Gene Therapy CRO Business (2019-2024) & (US$ Million)
 Table 70. Veristat Recent Development
 Table 71. Parexel Company Details
 Table 72. Parexel Business Overview
 Table 73. Parexel Cell and Gene Therapy CRO Product
 Table 74. Parexel Revenue in Cell and Gene Therapy CRO Business (2019-2024) & (US$ Million)
 Table 75. Parexel Recent Development
 Table 76. Charles River Laboratories Company Details
 Table 77. Charles River Laboratories Business Overview
 Table 78. Charles River Laboratories Cell and Gene Therapy CRO Product
 Table 79. Charles River Laboratories Revenue in Cell and Gene Therapy CRO Business (2019-2024) & (US$ Million)
 Table 80. Charles River Laboratories Recent Development
 Table 81. Catalent Pharma Solutions Company Details
 Table 82. Catalent Pharma Solutions Business Overview
 Table 83. Catalent Pharma Solutions Cell and Gene Therapy CRO Product
 Table 84. Catalent Pharma Solutions Revenue in Cell and Gene Therapy CRO Business (2019-2024) & (US$ Million)
 Table 85. Catalent Pharma Solutions Recent Development
 Table 86. Premier Research Company Details
 Table 87. Premier Research Business Overview
 Table 88. Premier Research Cell and Gene Therapy CRO Product
 Table 89. Premier Research Revenue in Cell and Gene Therapy CRO Business (2019-2024) & (US$ Million)
 Table 90. Premier Research Recent Development
 Table 91. Catalent Company Details
 Table 92. Catalent Business Overview
 Table 93. Catalent Cell and Gene Therapy CRO Product
 Table 94. Catalent Revenue in Cell and Gene Therapy CRO Business (2019-2024) & (US$ Million)
 Table 95. Catalent Recent Development
 Table 96. Vial Company Details
 Table 97. Vial Business Overview
 Table 98. Vial Cell and Gene Therapy CRO Product
 Table 99. Vial Revenue in Cell and Gene Therapy CRO Business (2019-2024) & (US$ Million)
 Table 100. Vial Recent Development
 Table 101. Noble Life Sciences Company Details
 Table 102. Noble Life Sciences Business Overview
 Table 103. Noble Life Sciences Cell and Gene Therapy CRO Product
 Table 104. Noble Life Sciences Revenue in Cell and Gene Therapy CRO Business (2019-2024) & (US$ Million)
 Table 105. Noble Life Sciences Recent Development
 Table 106. Ergomed Company Details
 Table 107. Ergomed Business Overview
 Table 108. Ergomed Cell and Gene Therapy CRO Product
 Table 109. Ergomed Revenue in Cell and Gene Therapy CRO Business (2019-2024) & (US$ Million)
 Table 110. Ergomed Recent Development
 Table 111. Research Programs/Design for This Report
 Table 112. Key Data Information from Secondary Sources
 Table 113. Key Data Information from Primary Sources
 Table 114. Authors List of This Report


List of Figures
 Figure 1. Cell and Gene Therapy CRO Picture
 Figure 2. Global Cell and Gene Therapy CRO Market Size Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global Cell and Gene Therapy CRO Market Share by Type: 2023 VS 2030
 Figure 4. Preclinical CRO Features
 Figure 5. Clinical CRO Features
 Figure 6. Global Cell and Gene Therapy CRO Market Size by Application (2024-2030) & (US$ Million)
 Figure 7. Global Cell and Gene Therapy CRO Market Share by Application: 2023 VS 2030
 Figure 8. SMBs Case Studies
 Figure 9. Large Companies Case Studies
 Figure 10. Cell and Gene Therapy CRO Report Years Considered
 Figure 11. Global Cell and Gene Therapy CRO Market Size (US$ Million), Year-over-Year: 2019-2030
 Figure 12. Global Cell and Gene Therapy CRO Market Size, (US$ Million), 2019 VS 2023 VS 2030
 Figure 13. Global Cell and Gene Therapy CRO Market Share by Region: 2023 VS 2030
 Figure 14. Global Cell and Gene Therapy CRO Market Share by Players in 2023
 Figure 15. Global Top Cell and Gene Therapy CRO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell and Gene Therapy CRO as of 2023)
 Figure 16. The Top 10 and 5 Players Market Share by Cell and Gene Therapy CRO Revenue in 2023
 Figure 17. North America Cell and Gene Therapy CRO Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 18. North America Cell and Gene Therapy CRO Market Share by Country (2019-2030)
 Figure 19. United States Cell and Gene Therapy CRO Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 20. Canada Cell and Gene Therapy CRO Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 21. Europe Cell and Gene Therapy CRO Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 22. Europe Cell and Gene Therapy CRO Market Share by Country (2019-2030)
 Figure 23. Germany Cell and Gene Therapy CRO Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 24. France Cell and Gene Therapy CRO Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 25. U.K. Cell and Gene Therapy CRO Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 26. Italy Cell and Gene Therapy CRO Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 27. Russia Cell and Gene Therapy CRO Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 28. Nordic Countries Cell and Gene Therapy CRO Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 29. Asia-Pacific Cell and Gene Therapy CRO Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 30. Asia-Pacific Cell and Gene Therapy CRO Market Share by Region (2019-2030)
 Figure 31. China Cell and Gene Therapy CRO Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 32. Japan Cell and Gene Therapy CRO Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 33. South Korea Cell and Gene Therapy CRO Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 34. Southeast Asia Cell and Gene Therapy CRO Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 35. India Cell and Gene Therapy CRO Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 36. Australia Cell and Gene Therapy CRO Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 37. Latin America Cell and Gene Therapy CRO Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 38. Latin America Cell and Gene Therapy CRO Market Share by Country (2019-2030)
 Figure 39. Mexico Cell and Gene Therapy CRO Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 40. Brazil Cell and Gene Therapy CRO Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 41. Middle East & Africa Cell and Gene Therapy CRO Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 42. Middle East & Africa Cell and Gene Therapy CRO Market Share by Country (2019-2030)
 Figure 43. Turkey Cell and Gene Therapy CRO Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 44. Saudi Arabia Cell and Gene Therapy CRO Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 45. UAE Cell and Gene Therapy CRO Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 46. Labcorp Revenue Growth Rate in Cell and Gene Therapy CRO Business (2019-2024)
 Figure 47. IQVIA Biotech Revenue Growth Rate in Cell and Gene Therapy CRO Business (2019-2024)
 Figure 48. PPD Revenue Growth Rate in Cell and Gene Therapy CRO Business (2019-2024)
 Figure 49. Medpace Revenue Growth Rate in Cell and Gene Therapy CRO Business (2019-2024)
 Figure 50. Veristat Revenue Growth Rate in Cell and Gene Therapy CRO Business (2019-2024)
 Figure 51. Parexel Revenue Growth Rate in Cell and Gene Therapy CRO Business (2019-2024)
 Figure 52. Charles River Laboratories Revenue Growth Rate in Cell and Gene Therapy CRO Business (2019-2024)
 Figure 53. Catalent Pharma Solutions Revenue Growth Rate in Cell and Gene Therapy CRO Business (2019-2024)
 Figure 54. Premier Research Revenue Growth Rate in Cell and Gene Therapy CRO Business (2019-2024)
 Figure 55. Catalent Revenue Growth Rate in Cell and Gene Therapy CRO Business (2019-2024)
 Figure 56. Vial Revenue Growth Rate in Cell and Gene Therapy CRO Business (2019-2024)
 Figure 57. Noble Life Sciences Revenue Growth Rate in Cell and Gene Therapy CRO Business (2019-2024)
 Figure 58. Ergomed Revenue Growth Rate in Cell and Gene Therapy CRO Business (2019-2024)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS

RELATED REPORTS

Global Residential Aged Care Software Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-20P19635
Mon Jun 09 00:00:00 UTC 2025

Add to Cart

Global Nitric Oxide Therapy System Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

120 Pages
Type: Report
Code: QYRE-Auto-13G13075
Mon Jun 09 00:00:00 UTC 2025

Add to Cart

Global Fractional Flow Reserve Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

120 Pages
Type: Report
Code: QYRE-Auto-39F2213
Mon Jun 09 00:00:00 UTC 2025

Add to Cart

Global Assisted Living Franchise Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-8U19550
Thu Jun 05 00:00:00 UTC 2025

Add to Cart